Global Hemoperfusion Production Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Hemoperfusion Production market size is predicted to grow from US$ 746 million in 2025 to US$ 1816 million in 2031; it is expected to grow at a CAGR of 16.0% from 2025 to 2031.
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body.
Global Hemoperfusion Production key players include Baxter (Gambro), Jafron Biomedical, Biosun Medical, Asahi-Kasei, etc. Global top four manufacturers hold a share over 80%.
China is the largest market, with a share over 65%, followed by Europe, and Japan, both have a share about 30 percent.
In terms of product, Resin Adsorption is the largest segment, with a share over 65%. And in terms of application, the largest application is Hepatic Encephalopathy, followed by Certain Autoimmune Diseases, Overdose, Specific Intoxications, etc.
LP Information, Inc. (LPI) ' newest research report, the “Hemoperfusion Production Industry Forecast” looks at past sales and reviews total world Hemoperfusion Production sales in 2024, providing a comprehensive analysis by region and market sector of projected Hemoperfusion Production sales for 2025 through 2031. With Hemoperfusion Production sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hemoperfusion Production industry.
This Insight Report provides a comprehensive analysis of the global Hemoperfusion Production landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hemoperfusion Production portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hemoperfusion Production market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hemoperfusion Production and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hemoperfusion Production.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemoperfusion Production market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Hemoperfusion Production market?
What factors are driving Hemoperfusion Production market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hemoperfusion Production market opportunities vary by end market size?
How does Hemoperfusion Production break out by Type, by Application?
The global Hemoperfusion Production market size is predicted to grow from US$ 746 million in 2025 to US$ 1816 million in 2031; it is expected to grow at a CAGR of 16.0% from 2025 to 2031.
Hemoperfusion is a treatment technique in which large volumes of the patient's blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body.
Global Hemoperfusion Production key players include Baxter (Gambro), Jafron Biomedical, Biosun Medical, Asahi-Kasei, etc. Global top four manufacturers hold a share over 80%.
China is the largest market, with a share over 65%, followed by Europe, and Japan, both have a share about 30 percent.
In terms of product, Resin Adsorption is the largest segment, with a share over 65%. And in terms of application, the largest application is Hepatic Encephalopathy, followed by Certain Autoimmune Diseases, Overdose, Specific Intoxications, etc.
LP Information, Inc. (LPI) ' newest research report, the “Hemoperfusion Production Industry Forecast” looks at past sales and reviews total world Hemoperfusion Production sales in 2024, providing a comprehensive analysis by region and market sector of projected Hemoperfusion Production sales for 2025 through 2031. With Hemoperfusion Production sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hemoperfusion Production industry.
This Insight Report provides a comprehensive analysis of the global Hemoperfusion Production landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hemoperfusion Production portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hemoperfusion Production market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hemoperfusion Production and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hemoperfusion Production.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemoperfusion Production market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Resin Adsorption
- Activated Carbon Adsorption
- Others
- Overdose
- Specific Intoxications
- Certain Autoimmune Diseases
- Hepatic Encephalopathy
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Jafron Biomedical
- Baxter (Gambro)
- Biosun Medical
- Toray Medical
- Asahi-Kasei
- Kaneka
- Zibo Kangbei
- Aier
- Cytosorbents
What is the 10-year outlook for the global Hemoperfusion Production market?
What factors are driving Hemoperfusion Production market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hemoperfusion Production market opportunities vary by end market size?
How does Hemoperfusion Production break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hemoperfusion Production Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Hemoperfusion Production by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Hemoperfusion Production by Country/Region, 2020, 2024 & 2031
2.2 Hemoperfusion Production Segment by Type
2.2.1 Resin Adsorption
2.2.2 Activated Carbon Adsorption
2.2.3 Others
2.3 Hemoperfusion Production Sales by Type
2.3.1 Global Hemoperfusion Production Sales Market Share by Type (2020-2025)
2.3.2 Global Hemoperfusion Production Revenue and Market Share by Type (2020-2025)
2.3.3 Global Hemoperfusion Production Sale Price by Type (2020-2025)
2.4 Hemoperfusion Production Segment by Application
2.4.1 Overdose
2.4.2 Specific Intoxications
2.4.3 Certain Autoimmune Diseases
2.4.4 Hepatic Encephalopathy
2.4.5 Others
2.5 Hemoperfusion Production Sales by Application
2.5.1 Global Hemoperfusion Production Sale Market Share by Application (2020-2025)
2.5.2 Global Hemoperfusion Production Revenue and Market Share by Application (2020-2025)
2.5.3 Global Hemoperfusion Production Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Hemoperfusion Production Breakdown Data by Company
3.1.1 Global Hemoperfusion Production Annual Sales by Company (2020-2025)
3.1.2 Global Hemoperfusion Production Sales Market Share by Company (2020-2025)
3.2 Global Hemoperfusion Production Annual Revenue by Company (2020-2025)
3.2.1 Global Hemoperfusion Production Revenue by Company (2020-2025)
3.2.2 Global Hemoperfusion Production Revenue Market Share by Company (2020-2025)
3.3 Global Hemoperfusion Production Sale Price by Company
3.4 Key Manufacturers Hemoperfusion Production Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hemoperfusion Production Product Location Distribution
3.4.2 Players Hemoperfusion Production Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HEMOPERFUSION PRODUCTION BY GEOGRAPHIC REGION
4.1 World Historic Hemoperfusion Production Market Size by Geographic Region (2020-2025)
4.1.1 Global Hemoperfusion Production Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Hemoperfusion Production Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Hemoperfusion Production Market Size by Country/Region (2020-2025)
4.2.1 Global Hemoperfusion Production Annual Sales by Country/Region (2020-2025)
4.2.2 Global Hemoperfusion Production Annual Revenue by Country/Region (2020-2025)
4.3 Americas Hemoperfusion Production Sales Growth
4.4 APAC Hemoperfusion Production Sales Growth
4.5 Europe Hemoperfusion Production Sales Growth
4.6 Middle East & Africa Hemoperfusion Production Sales Growth
5 AMERICAS
5.1 Americas Hemoperfusion Production Sales by Country
5.1.1 Americas Hemoperfusion Production Sales by Country (2020-2025)
5.1.2 Americas Hemoperfusion Production Revenue by Country (2020-2025)
5.2 Americas Hemoperfusion Production Sales by Type (2020-2025)
5.3 Americas Hemoperfusion Production Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hemoperfusion Production Sales by Region
6.1.1 APAC Hemoperfusion Production Sales by Region (2020-2025)
6.1.2 APAC Hemoperfusion Production Revenue by Region (2020-2025)
6.2 APAC Hemoperfusion Production Sales by Type (2020-2025)
6.3 APAC Hemoperfusion Production Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hemoperfusion Production by Country
7.1.1 Europe Hemoperfusion Production Sales by Country (2020-2025)
7.1.2 Europe Hemoperfusion Production Revenue by Country (2020-2025)
7.2 Europe Hemoperfusion Production Sales by Type (2020-2025)
7.3 Europe Hemoperfusion Production Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hemoperfusion Production by Country
8.1.1 Middle East & Africa Hemoperfusion Production Sales by Country (2020-2025)
8.1.2 Middle East & Africa Hemoperfusion Production Revenue by Country (2020-2025)
8.2 Middle East & Africa Hemoperfusion Production Sales by Type (2020-2025)
8.3 Middle East & Africa Hemoperfusion Production Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hemoperfusion Production
10.3 Manufacturing Process Analysis of Hemoperfusion Production
10.4 Industry Chain Structure of Hemoperfusion Production
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hemoperfusion Production Distributors
11.3 Hemoperfusion Production Customer
12 WORLD FORECAST REVIEW FOR HEMOPERFUSION PRODUCTION BY GEOGRAPHIC REGION
12.1 Global Hemoperfusion Production Market Size Forecast by Region
12.1.1 Global Hemoperfusion Production Forecast by Region (2026-2031)
12.1.2 Global Hemoperfusion Production Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Hemoperfusion Production Forecast by Type (2026-2031)
12.7 Global Hemoperfusion Production Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Jafron Biomedical
13.1.1 Jafron Biomedical Company Information
13.1.2 Jafron Biomedical Hemoperfusion Production Product Portfolios and Specifications
13.1.3 Jafron Biomedical Hemoperfusion Production Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Jafron Biomedical Main Business Overview
13.1.5 Jafron Biomedical Latest Developments
13.2 Baxter (Gambro)
13.2.1 Baxter (Gambro) Company Information
13.2.2 Baxter (Gambro) Hemoperfusion Production Product Portfolios and Specifications
13.2.3 Baxter (Gambro) Hemoperfusion Production Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Baxter (Gambro) Main Business Overview
13.2.5 Baxter (Gambro) Latest Developments
13.3 Biosun Medical
13.3.1 Biosun Medical Company Information
13.3.2 Biosun Medical Hemoperfusion Production Product Portfolios and Specifications
13.3.3 Biosun Medical Hemoperfusion Production Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Biosun Medical Main Business Overview
13.3.5 Biosun Medical Latest Developments
13.4 Toray Medical
13.4.1 Toray Medical Company Information
13.4.2 Toray Medical Hemoperfusion Production Product Portfolios and Specifications
13.4.3 Toray Medical Hemoperfusion Production Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Toray Medical Main Business Overview
13.4.5 Toray Medical Latest Developments
13.5 Asahi-Kasei
13.5.1 Asahi-Kasei Company Information
13.5.2 Asahi-Kasei Hemoperfusion Production Product Portfolios and Specifications
13.5.3 Asahi-Kasei Hemoperfusion Production Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Asahi-Kasei Main Business Overview
13.5.5 Asahi-Kasei Latest Developments
13.6 Kaneka
13.6.1 Kaneka Company Information
13.6.2 Kaneka Hemoperfusion Production Product Portfolios and Specifications
13.6.3 Kaneka Hemoperfusion Production Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Kaneka Main Business Overview
13.6.5 Kaneka Latest Developments
13.7 Zibo Kangbei
13.7.1 Zibo Kangbei Company Information
13.7.2 Zibo Kangbei Hemoperfusion Production Product Portfolios and Specifications
13.7.3 Zibo Kangbei Hemoperfusion Production Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Zibo Kangbei Main Business Overview
13.7.5 Zibo Kangbei Latest Developments
13.8 Aier
13.8.1 Aier Company Information
13.8.2 Aier Hemoperfusion Production Product Portfolios and Specifications
13.8.3 Aier Hemoperfusion Production Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Aier Main Business Overview
13.8.5 Aier Latest Developments
13.9 Cytosorbents
13.9.1 Cytosorbents Company Information
13.9.2 Cytosorbents Hemoperfusion Production Product Portfolios and Specifications
13.9.3 Cytosorbents Hemoperfusion Production Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Cytosorbents Main Business Overview
13.9.5 Cytosorbents Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hemoperfusion Production Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Hemoperfusion Production by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Hemoperfusion Production by Country/Region, 2020, 2024 & 2031
2.2 Hemoperfusion Production Segment by Type
2.2.1 Resin Adsorption
2.2.2 Activated Carbon Adsorption
2.2.3 Others
2.3 Hemoperfusion Production Sales by Type
2.3.1 Global Hemoperfusion Production Sales Market Share by Type (2020-2025)
2.3.2 Global Hemoperfusion Production Revenue and Market Share by Type (2020-2025)
2.3.3 Global Hemoperfusion Production Sale Price by Type (2020-2025)
2.4 Hemoperfusion Production Segment by Application
2.4.1 Overdose
2.4.2 Specific Intoxications
2.4.3 Certain Autoimmune Diseases
2.4.4 Hepatic Encephalopathy
2.4.5 Others
2.5 Hemoperfusion Production Sales by Application
2.5.1 Global Hemoperfusion Production Sale Market Share by Application (2020-2025)
2.5.2 Global Hemoperfusion Production Revenue and Market Share by Application (2020-2025)
2.5.3 Global Hemoperfusion Production Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Hemoperfusion Production Breakdown Data by Company
3.1.1 Global Hemoperfusion Production Annual Sales by Company (2020-2025)
3.1.2 Global Hemoperfusion Production Sales Market Share by Company (2020-2025)
3.2 Global Hemoperfusion Production Annual Revenue by Company (2020-2025)
3.2.1 Global Hemoperfusion Production Revenue by Company (2020-2025)
3.2.2 Global Hemoperfusion Production Revenue Market Share by Company (2020-2025)
3.3 Global Hemoperfusion Production Sale Price by Company
3.4 Key Manufacturers Hemoperfusion Production Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hemoperfusion Production Product Location Distribution
3.4.2 Players Hemoperfusion Production Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HEMOPERFUSION PRODUCTION BY GEOGRAPHIC REGION
4.1 World Historic Hemoperfusion Production Market Size by Geographic Region (2020-2025)
4.1.1 Global Hemoperfusion Production Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Hemoperfusion Production Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Hemoperfusion Production Market Size by Country/Region (2020-2025)
4.2.1 Global Hemoperfusion Production Annual Sales by Country/Region (2020-2025)
4.2.2 Global Hemoperfusion Production Annual Revenue by Country/Region (2020-2025)
4.3 Americas Hemoperfusion Production Sales Growth
4.4 APAC Hemoperfusion Production Sales Growth
4.5 Europe Hemoperfusion Production Sales Growth
4.6 Middle East & Africa Hemoperfusion Production Sales Growth
5 AMERICAS
5.1 Americas Hemoperfusion Production Sales by Country
5.1.1 Americas Hemoperfusion Production Sales by Country (2020-2025)
5.1.2 Americas Hemoperfusion Production Revenue by Country (2020-2025)
5.2 Americas Hemoperfusion Production Sales by Type (2020-2025)
5.3 Americas Hemoperfusion Production Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hemoperfusion Production Sales by Region
6.1.1 APAC Hemoperfusion Production Sales by Region (2020-2025)
6.1.2 APAC Hemoperfusion Production Revenue by Region (2020-2025)
6.2 APAC Hemoperfusion Production Sales by Type (2020-2025)
6.3 APAC Hemoperfusion Production Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Hemoperfusion Production by Country
7.1.1 Europe Hemoperfusion Production Sales by Country (2020-2025)
7.1.2 Europe Hemoperfusion Production Revenue by Country (2020-2025)
7.2 Europe Hemoperfusion Production Sales by Type (2020-2025)
7.3 Europe Hemoperfusion Production Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hemoperfusion Production by Country
8.1.1 Middle East & Africa Hemoperfusion Production Sales by Country (2020-2025)
8.1.2 Middle East & Africa Hemoperfusion Production Revenue by Country (2020-2025)
8.2 Middle East & Africa Hemoperfusion Production Sales by Type (2020-2025)
8.3 Middle East & Africa Hemoperfusion Production Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hemoperfusion Production
10.3 Manufacturing Process Analysis of Hemoperfusion Production
10.4 Industry Chain Structure of Hemoperfusion Production
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hemoperfusion Production Distributors
11.3 Hemoperfusion Production Customer
12 WORLD FORECAST REVIEW FOR HEMOPERFUSION PRODUCTION BY GEOGRAPHIC REGION
12.1 Global Hemoperfusion Production Market Size Forecast by Region
12.1.1 Global Hemoperfusion Production Forecast by Region (2026-2031)
12.1.2 Global Hemoperfusion Production Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Hemoperfusion Production Forecast by Type (2026-2031)
12.7 Global Hemoperfusion Production Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Jafron Biomedical
13.1.1 Jafron Biomedical Company Information
13.1.2 Jafron Biomedical Hemoperfusion Production Product Portfolios and Specifications
13.1.3 Jafron Biomedical Hemoperfusion Production Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Jafron Biomedical Main Business Overview
13.1.5 Jafron Biomedical Latest Developments
13.2 Baxter (Gambro)
13.2.1 Baxter (Gambro) Company Information
13.2.2 Baxter (Gambro) Hemoperfusion Production Product Portfolios and Specifications
13.2.3 Baxter (Gambro) Hemoperfusion Production Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Baxter (Gambro) Main Business Overview
13.2.5 Baxter (Gambro) Latest Developments
13.3 Biosun Medical
13.3.1 Biosun Medical Company Information
13.3.2 Biosun Medical Hemoperfusion Production Product Portfolios and Specifications
13.3.3 Biosun Medical Hemoperfusion Production Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Biosun Medical Main Business Overview
13.3.5 Biosun Medical Latest Developments
13.4 Toray Medical
13.4.1 Toray Medical Company Information
13.4.2 Toray Medical Hemoperfusion Production Product Portfolios and Specifications
13.4.3 Toray Medical Hemoperfusion Production Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Toray Medical Main Business Overview
13.4.5 Toray Medical Latest Developments
13.5 Asahi-Kasei
13.5.1 Asahi-Kasei Company Information
13.5.2 Asahi-Kasei Hemoperfusion Production Product Portfolios and Specifications
13.5.3 Asahi-Kasei Hemoperfusion Production Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Asahi-Kasei Main Business Overview
13.5.5 Asahi-Kasei Latest Developments
13.6 Kaneka
13.6.1 Kaneka Company Information
13.6.2 Kaneka Hemoperfusion Production Product Portfolios and Specifications
13.6.3 Kaneka Hemoperfusion Production Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Kaneka Main Business Overview
13.6.5 Kaneka Latest Developments
13.7 Zibo Kangbei
13.7.1 Zibo Kangbei Company Information
13.7.2 Zibo Kangbei Hemoperfusion Production Product Portfolios and Specifications
13.7.3 Zibo Kangbei Hemoperfusion Production Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Zibo Kangbei Main Business Overview
13.7.5 Zibo Kangbei Latest Developments
13.8 Aier
13.8.1 Aier Company Information
13.8.2 Aier Hemoperfusion Production Product Portfolios and Specifications
13.8.3 Aier Hemoperfusion Production Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Aier Main Business Overview
13.8.5 Aier Latest Developments
13.9 Cytosorbents
13.9.1 Cytosorbents Company Information
13.9.2 Cytosorbents Hemoperfusion Production Product Portfolios and Specifications
13.9.3 Cytosorbents Hemoperfusion Production Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Cytosorbents Main Business Overview
13.9.5 Cytosorbents Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Hemoperfusion Production Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Hemoperfusion Production Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Resin Adsorption
Table 4. Major Players of Activated Carbon Adsorption
Table 5. Major Players of Others
Table 6. Global Hemoperfusion Production Sales byType (2020-2025) & (K Units)
Table 7. Global Hemoperfusion Production Sales Market Share byType (2020-2025)
Table 8. Global Hemoperfusion Production Revenue byType (2020-2025) & ($ million)
Table 9. Global Hemoperfusion Production Revenue Market Share byType (2020-2025)
Table 10. Global Hemoperfusion Production Sale Price byType (2020-2025) & (USD/Unit)
Table 11. Global Hemoperfusion Production Sale by Application (2020-2025) & (K Units)
Table 12. Global Hemoperfusion Production Sale Market Share by Application (2020-2025)
Table 13. Global Hemoperfusion Production Revenue by Application (2020-2025) & ($ million)
Table 14. Global Hemoperfusion Production Revenue Market Share by Application (2020-2025)
Table 15. Global Hemoperfusion Production Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Hemoperfusion Production Sales by Company (2020-2025) & (K Units)
Table 17. Global Hemoperfusion Production Sales Market Share by Company (2020-2025)
Table 18. Global Hemoperfusion Production Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Hemoperfusion Production Revenue Market Share by Company (2020-2025)
Table 20. Global Hemoperfusion Production Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Hemoperfusion Production Producing Area Distribution and Sales Area
Table 22. Players Hemoperfusion Production Products Offered
Table 23. Hemoperfusion Production Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Hemoperfusion Production Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Hemoperfusion Production Sales Market Share Geographic Region (2020-2025)
Table 28. Global Hemoperfusion Production Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Hemoperfusion Production Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Hemoperfusion Production Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Hemoperfusion Production Sales Market Share by Country/Region (2020-2025)
Table 32. Global Hemoperfusion Production Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Hemoperfusion Production Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Hemoperfusion Production Sales by Country (2020-2025) & (K Units)
Table 35. Americas Hemoperfusion Production Sales Market Share by Country (2020-2025)
Table 36. Americas Hemoperfusion Production Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Hemoperfusion Production Sales byType (2020-2025) & (K Units)
Table 38. Americas Hemoperfusion Production Sales by Application (2020-2025) & (K Units)
Table 39. APAC Hemoperfusion Production Sales by Region (2020-2025) & (K Units)
Table 40. APAC Hemoperfusion Production Sales Market Share by Region (2020-2025)
Table 41. APAC Hemoperfusion Production Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Hemoperfusion Production Sales byType (2020-2025) & (K Units)
Table 43. APAC Hemoperfusion Production Sales by Application (2020-2025) & (K Units)
Table 44. Europe Hemoperfusion Production Sales by Country (2020-2025) & (K Units)
Table 45. Europe Hemoperfusion Production Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Hemoperfusion Production Sales byType (2020-2025) & (K Units)
Table 47. Europe Hemoperfusion Production Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Hemoperfusion Production Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Hemoperfusion Production Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Hemoperfusion Production Sales byType (2020-2025) & (K Units)
Table 51. Middle East & Africa Hemoperfusion Production Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Hemoperfusion Production
Table 53. Key Market Challenges & Risks of Hemoperfusion Production
Table 54. Key IndustryTrends of Hemoperfusion Production
Table 55. Hemoperfusion Production Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Hemoperfusion Production Distributors List
Table 58. Hemoperfusion Production Customer List
Table 59. Global Hemoperfusion Production SalesForecast by Region (2026-2031) & (K Units)
Table 60. Global Hemoperfusion Production RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Hemoperfusion Production SalesForecast by Country (2026-2031) & (K Units)
Table 62. Americas Hemoperfusion Production Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Hemoperfusion Production SalesForecast by Region (2026-2031) & (K Units)
Table 64. APAC Hemoperfusion Production Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Hemoperfusion Production SalesForecast by Country (2026-2031) & (K Units)
Table 66. Europe Hemoperfusion Production RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Hemoperfusion Production SalesForecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Hemoperfusion Production RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Hemoperfusion Production SalesForecast byType (2026-2031) & (K Units)
Table 70. Global Hemoperfusion Production RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Hemoperfusion Production SalesForecast by Application (2026-2031) & (K Units)
Table 72. Global Hemoperfusion Production RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Jafron Biomedical Basic Information, Hemoperfusion Production Manufacturing Base, Sales Area and Its Competitors
Table 74. Jafron Biomedical Hemoperfusion Production Product Portfolios and Specifications
Table 75. Jafron Biomedical Hemoperfusion Production Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Jafron Biomedical Main Business
Table 77. Jafron Biomedical Latest Developments
Table 78. Baxter (Gambro) Basic Information, Hemoperfusion Production Manufacturing Base, Sales Area and Its Competitors
Table 79. Baxter (Gambro) Hemoperfusion Production Product Portfolios and Specifications
Table 80. Baxter (Gambro) Hemoperfusion Production Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Baxter (Gambro) Main Business
Table 82. Baxter (Gambro) Latest Developments
Table 83. Biosun Medical Basic Information, Hemoperfusion Production Manufacturing Base, Sales Area and Its Competitors
Table 84. Biosun Medical Hemoperfusion Production Product Portfolios and Specifications
Table 85. Biosun Medical Hemoperfusion Production Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Biosun Medical Main Business
Table 87. Biosun Medical Latest Developments
Table 88.Toray Medical Basic Information, Hemoperfusion Production Manufacturing Base, Sales Area and Its Competitors
Table 89.Toray Medical Hemoperfusion Production Product Portfolios and Specifications
Table 90.Toray Medical Hemoperfusion Production Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91.Toray Medical Main Business
Table 92.Toray Medical Latest Developments
Table 93. Asahi-Kasei Basic Information, Hemoperfusion Production Manufacturing Base, Sales Area and Its Competitors
Table 94. Asahi-Kasei Hemoperfusion Production Product Portfolios and Specifications
Table 95. Asahi-Kasei Hemoperfusion Production Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Asahi-Kasei Main Business
Table 97. Asahi-Kasei Latest Developments
Table 98. Kaneka Basic Information, Hemoperfusion Production Manufacturing Base, Sales Area and Its Competitors
Table 99. Kaneka Hemoperfusion Production Product Portfolios and Specifications
Table 100. Kaneka Hemoperfusion Production Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Kaneka Main Business
Table 102. Kaneka Latest Developments
Table 103. Zibo Kangbei Basic Information, Hemoperfusion Production Manufacturing Base, Sales Area and Its Competitors
Table 104. Zibo Kangbei Hemoperfusion Production Product Portfolios and Specifications
Table 105. Zibo Kangbei Hemoperfusion Production Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Zibo Kangbei Main Business
Table 107. Zibo Kangbei Latest Developments
Table 108. Aier Basic Information, Hemoperfusion Production Manufacturing Base, Sales Area and Its Competitors
Table 109. Aier Hemoperfusion Production Product Portfolios and Specifications
Table 110. Aier Hemoperfusion Production Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Aier Main Business
Table 112. Aier Latest Developments
Table 113. Cytosorbents Basic Information, Hemoperfusion Production Manufacturing Base, Sales Area and Its Competitors
Table 114. Cytosorbents Hemoperfusion Production Product Portfolios and Specifications
Table 115. Cytosorbents Hemoperfusion Production Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Cytosorbents Main Business
Table 117. Cytosorbents Latest Developments
Table 1. Hemoperfusion Production Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Hemoperfusion Production Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Resin Adsorption
Table 4. Major Players of Activated Carbon Adsorption
Table 5. Major Players of Others
Table 6. Global Hemoperfusion Production Sales byType (2020-2025) & (K Units)
Table 7. Global Hemoperfusion Production Sales Market Share byType (2020-2025)
Table 8. Global Hemoperfusion Production Revenue byType (2020-2025) & ($ million)
Table 9. Global Hemoperfusion Production Revenue Market Share byType (2020-2025)
Table 10. Global Hemoperfusion Production Sale Price byType (2020-2025) & (USD/Unit)
Table 11. Global Hemoperfusion Production Sale by Application (2020-2025) & (K Units)
Table 12. Global Hemoperfusion Production Sale Market Share by Application (2020-2025)
Table 13. Global Hemoperfusion Production Revenue by Application (2020-2025) & ($ million)
Table 14. Global Hemoperfusion Production Revenue Market Share by Application (2020-2025)
Table 15. Global Hemoperfusion Production Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Hemoperfusion Production Sales by Company (2020-2025) & (K Units)
Table 17. Global Hemoperfusion Production Sales Market Share by Company (2020-2025)
Table 18. Global Hemoperfusion Production Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Hemoperfusion Production Revenue Market Share by Company (2020-2025)
Table 20. Global Hemoperfusion Production Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Hemoperfusion Production Producing Area Distribution and Sales Area
Table 22. Players Hemoperfusion Production Products Offered
Table 23. Hemoperfusion Production Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Hemoperfusion Production Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Hemoperfusion Production Sales Market Share Geographic Region (2020-2025)
Table 28. Global Hemoperfusion Production Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Hemoperfusion Production Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Hemoperfusion Production Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Hemoperfusion Production Sales Market Share by Country/Region (2020-2025)
Table 32. Global Hemoperfusion Production Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Hemoperfusion Production Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Hemoperfusion Production Sales by Country (2020-2025) & (K Units)
Table 35. Americas Hemoperfusion Production Sales Market Share by Country (2020-2025)
Table 36. Americas Hemoperfusion Production Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Hemoperfusion Production Sales byType (2020-2025) & (K Units)
Table 38. Americas Hemoperfusion Production Sales by Application (2020-2025) & (K Units)
Table 39. APAC Hemoperfusion Production Sales by Region (2020-2025) & (K Units)
Table 40. APAC Hemoperfusion Production Sales Market Share by Region (2020-2025)
Table 41. APAC Hemoperfusion Production Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Hemoperfusion Production Sales byType (2020-2025) & (K Units)
Table 43. APAC Hemoperfusion Production Sales by Application (2020-2025) & (K Units)
Table 44. Europe Hemoperfusion Production Sales by Country (2020-2025) & (K Units)
Table 45. Europe Hemoperfusion Production Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Hemoperfusion Production Sales byType (2020-2025) & (K Units)
Table 47. Europe Hemoperfusion Production Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Hemoperfusion Production Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Hemoperfusion Production Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Hemoperfusion Production Sales byType (2020-2025) & (K Units)
Table 51. Middle East & Africa Hemoperfusion Production Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Hemoperfusion Production
Table 53. Key Market Challenges & Risks of Hemoperfusion Production
Table 54. Key IndustryTrends of Hemoperfusion Production
Table 55. Hemoperfusion Production Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Hemoperfusion Production Distributors List
Table 58. Hemoperfusion Production Customer List
Table 59. Global Hemoperfusion Production SalesForecast by Region (2026-2031) & (K Units)
Table 60. Global Hemoperfusion Production RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Hemoperfusion Production SalesForecast by Country (2026-2031) & (K Units)
Table 62. Americas Hemoperfusion Production Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Hemoperfusion Production SalesForecast by Region (2026-2031) & (K Units)
Table 64. APAC Hemoperfusion Production Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Hemoperfusion Production SalesForecast by Country (2026-2031) & (K Units)
Table 66. Europe Hemoperfusion Production RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Hemoperfusion Production SalesForecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Hemoperfusion Production RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Hemoperfusion Production SalesForecast byType (2026-2031) & (K Units)
Table 70. Global Hemoperfusion Production RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Hemoperfusion Production SalesForecast by Application (2026-2031) & (K Units)
Table 72. Global Hemoperfusion Production RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Jafron Biomedical Basic Information, Hemoperfusion Production Manufacturing Base, Sales Area and Its Competitors
Table 74. Jafron Biomedical Hemoperfusion Production Product Portfolios and Specifications
Table 75. Jafron Biomedical Hemoperfusion Production Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Jafron Biomedical Main Business
Table 77. Jafron Biomedical Latest Developments
Table 78. Baxter (Gambro) Basic Information, Hemoperfusion Production Manufacturing Base, Sales Area and Its Competitors
Table 79. Baxter (Gambro) Hemoperfusion Production Product Portfolios and Specifications
Table 80. Baxter (Gambro) Hemoperfusion Production Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Baxter (Gambro) Main Business
Table 82. Baxter (Gambro) Latest Developments
Table 83. Biosun Medical Basic Information, Hemoperfusion Production Manufacturing Base, Sales Area and Its Competitors
Table 84. Biosun Medical Hemoperfusion Production Product Portfolios and Specifications
Table 85. Biosun Medical Hemoperfusion Production Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Biosun Medical Main Business
Table 87. Biosun Medical Latest Developments
Table 88.Toray Medical Basic Information, Hemoperfusion Production Manufacturing Base, Sales Area and Its Competitors
Table 89.Toray Medical Hemoperfusion Production Product Portfolios and Specifications
Table 90.Toray Medical Hemoperfusion Production Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91.Toray Medical Main Business
Table 92.Toray Medical Latest Developments
Table 93. Asahi-Kasei Basic Information, Hemoperfusion Production Manufacturing Base, Sales Area and Its Competitors
Table 94. Asahi-Kasei Hemoperfusion Production Product Portfolios and Specifications
Table 95. Asahi-Kasei Hemoperfusion Production Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Asahi-Kasei Main Business
Table 97. Asahi-Kasei Latest Developments
Table 98. Kaneka Basic Information, Hemoperfusion Production Manufacturing Base, Sales Area and Its Competitors
Table 99. Kaneka Hemoperfusion Production Product Portfolios and Specifications
Table 100. Kaneka Hemoperfusion Production Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Kaneka Main Business
Table 102. Kaneka Latest Developments
Table 103. Zibo Kangbei Basic Information, Hemoperfusion Production Manufacturing Base, Sales Area and Its Competitors
Table 104. Zibo Kangbei Hemoperfusion Production Product Portfolios and Specifications
Table 105. Zibo Kangbei Hemoperfusion Production Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Zibo Kangbei Main Business
Table 107. Zibo Kangbei Latest Developments
Table 108. Aier Basic Information, Hemoperfusion Production Manufacturing Base, Sales Area and Its Competitors
Table 109. Aier Hemoperfusion Production Product Portfolios and Specifications
Table 110. Aier Hemoperfusion Production Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Aier Main Business
Table 112. Aier Latest Developments
Table 113. Cytosorbents Basic Information, Hemoperfusion Production Manufacturing Base, Sales Area and Its Competitors
Table 114. Cytosorbents Hemoperfusion Production Product Portfolios and Specifications
Table 115. Cytosorbents Hemoperfusion Production Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Cytosorbents Main Business
Table 117. Cytosorbents Latest Developments
LIST OF FIGURES
Figure 1. Picture of Hemoperfusion Production
Figure 2. Hemoperfusion Production Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hemoperfusion Production Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Hemoperfusion Production Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Hemoperfusion Production Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Hemoperfusion Production Sales Market Share by Country/Region (2024)
Figure 10. Hemoperfusion Production Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Resin Adsorption
Figure 12. Product Picture of Activated Carbon Adsorption
Figure 13. Product Picture of Others
Figure 14. Global Hemoperfusion Production Sales Market Share byType in 2025
Figure 15. Global Hemoperfusion Production Revenue Market Share byType (2020-2025)
Figure 16. Hemoperfusion Production Consumed in Overdose
Figure 17. Global Hemoperfusion Production Market: Overdose (2020-2025) & (K Units)
Figure 18. Hemoperfusion Production Consumed in Specific Intoxications
Figure 19. Global Hemoperfusion Production Market: Specific Intoxications (2020-2025) & (K Units)
Figure 20. Hemoperfusion Production Consumed in Certain Autoimmune Diseases
Figure 21. Global Hemoperfusion Production Market: Certain Autoimmune Diseases (2020-2025) & (K Units)
Figure 22. Hemoperfusion Production Consumed in Hepatic Encephalopathy
Figure 23. Global Hemoperfusion Production Market: Hepatic Encephalopathy (2020-2025) & (K Units)
Figure 24. Hemoperfusion Production Consumed in Others
Figure 25. Global Hemoperfusion Production Market: Others (2020-2025) & (K Units)
Figure 26. Global Hemoperfusion Production Sale Market Share by Application (2024)
Figure 27. Global Hemoperfusion Production Revenue Market Share by Application in 2025
Figure 28. Hemoperfusion Production Sales by Company in 2025 (K Units)
Figure 29. Global Hemoperfusion Production Sales Market Share by Company in 2025
Figure 30. Hemoperfusion Production Revenue by Company in 2025 ($ millions)
Figure 31. Global Hemoperfusion Production Revenue Market Share by Company in 2025
Figure 32. Global Hemoperfusion Production Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Hemoperfusion Production Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Hemoperfusion Production Sales 2020-2025 (K Units)
Figure 35. Americas Hemoperfusion Production Revenue 2020-2025 ($ millions)
Figure 36. APAC Hemoperfusion Production Sales 2020-2025 (K Units)
Figure 37. APAC Hemoperfusion Production Revenue 2020-2025 ($ millions)
Figure 38. Europe Hemoperfusion Production Sales 2020-2025 (K Units)
Figure 39. Europe Hemoperfusion Production Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Hemoperfusion Production Sales 2020-2025 (K Units)
Figure 41. Middle East & Africa Hemoperfusion Production Revenue 2020-2025 ($ millions)
Figure 42. Americas Hemoperfusion Production Sales Market Share by Country in 2025
Figure 43. Americas Hemoperfusion Production Revenue Market Share by Country (2020-2025)
Figure 44. Americas Hemoperfusion Production Sales Market Share byType (2020-2025)
Figure 45. Americas Hemoperfusion Production Sales Market Share by Application (2020-2025)
Figure 46. United States Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Hemoperfusion Production Sales Market Share by Region in 2025
Figure 51. APAC Hemoperfusion Production Revenue Market Share by Region (2020-2025)
Figure 52. APAC Hemoperfusion Production Sales Market Share byType (2020-2025)
Figure 53. APAC Hemoperfusion Production Sales Market Share by Application (2020-2025)
Figure 54. China Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 58. India Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 60. ChinaTaiwan Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Hemoperfusion Production Sales Market Share by Country in 2025
Figure 62. Europe Hemoperfusion Production Revenue Market Share by Country (2020-2025)
Figure 63. Europe Hemoperfusion Production Sales Market Share byType (2020-2025)
Figure 64. Europe Hemoperfusion Production Sales Market Share by Application (2020-2025)
Figure 65. Germany Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 66.France Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Hemoperfusion Production Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Hemoperfusion Production Sales Market Share byType (2020-2025)
Figure 72. Middle East & Africa Hemoperfusion Production Sales Market Share by Application (2020-2025)
Figure 73. Egypt Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 76.Turkey Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Hemoperfusion Production in 2025
Figure 79. Manufacturing Process Analysis of Hemoperfusion Production
Figure 80. Industry Chain Structure of Hemoperfusion Production
Figure 81. Channels of Distribution
Figure 82. Global Hemoperfusion Production Sales MarketForecast by Region (2026-2031)
Figure 83. Global Hemoperfusion Production Revenue Market ShareForecast by Region (2026-2031)
Figure 84. Global Hemoperfusion Production Sales Market ShareForecast byType (2026-2031)
Figure 85. Global Hemoperfusion Production Revenue Market ShareForecast byType (2026-2031)
Figure 86. Global Hemoperfusion Production Sales Market ShareForecast by Application (2026-2031)
Figure 87. Global Hemoperfusion Production Revenue Market ShareForecast by Application (2026-2031)
Figure 1. Picture of Hemoperfusion Production
Figure 2. Hemoperfusion Production Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hemoperfusion Production Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Hemoperfusion Production Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Hemoperfusion Production Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Hemoperfusion Production Sales Market Share by Country/Region (2024)
Figure 10. Hemoperfusion Production Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Resin Adsorption
Figure 12. Product Picture of Activated Carbon Adsorption
Figure 13. Product Picture of Others
Figure 14. Global Hemoperfusion Production Sales Market Share byType in 2025
Figure 15. Global Hemoperfusion Production Revenue Market Share byType (2020-2025)
Figure 16. Hemoperfusion Production Consumed in Overdose
Figure 17. Global Hemoperfusion Production Market: Overdose (2020-2025) & (K Units)
Figure 18. Hemoperfusion Production Consumed in Specific Intoxications
Figure 19. Global Hemoperfusion Production Market: Specific Intoxications (2020-2025) & (K Units)
Figure 20. Hemoperfusion Production Consumed in Certain Autoimmune Diseases
Figure 21. Global Hemoperfusion Production Market: Certain Autoimmune Diseases (2020-2025) & (K Units)
Figure 22. Hemoperfusion Production Consumed in Hepatic Encephalopathy
Figure 23. Global Hemoperfusion Production Market: Hepatic Encephalopathy (2020-2025) & (K Units)
Figure 24. Hemoperfusion Production Consumed in Others
Figure 25. Global Hemoperfusion Production Market: Others (2020-2025) & (K Units)
Figure 26. Global Hemoperfusion Production Sale Market Share by Application (2024)
Figure 27. Global Hemoperfusion Production Revenue Market Share by Application in 2025
Figure 28. Hemoperfusion Production Sales by Company in 2025 (K Units)
Figure 29. Global Hemoperfusion Production Sales Market Share by Company in 2025
Figure 30. Hemoperfusion Production Revenue by Company in 2025 ($ millions)
Figure 31. Global Hemoperfusion Production Revenue Market Share by Company in 2025
Figure 32. Global Hemoperfusion Production Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Hemoperfusion Production Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Hemoperfusion Production Sales 2020-2025 (K Units)
Figure 35. Americas Hemoperfusion Production Revenue 2020-2025 ($ millions)
Figure 36. APAC Hemoperfusion Production Sales 2020-2025 (K Units)
Figure 37. APAC Hemoperfusion Production Revenue 2020-2025 ($ millions)
Figure 38. Europe Hemoperfusion Production Sales 2020-2025 (K Units)
Figure 39. Europe Hemoperfusion Production Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Hemoperfusion Production Sales 2020-2025 (K Units)
Figure 41. Middle East & Africa Hemoperfusion Production Revenue 2020-2025 ($ millions)
Figure 42. Americas Hemoperfusion Production Sales Market Share by Country in 2025
Figure 43. Americas Hemoperfusion Production Revenue Market Share by Country (2020-2025)
Figure 44. Americas Hemoperfusion Production Sales Market Share byType (2020-2025)
Figure 45. Americas Hemoperfusion Production Sales Market Share by Application (2020-2025)
Figure 46. United States Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Hemoperfusion Production Sales Market Share by Region in 2025
Figure 51. APAC Hemoperfusion Production Revenue Market Share by Region (2020-2025)
Figure 52. APAC Hemoperfusion Production Sales Market Share byType (2020-2025)
Figure 53. APAC Hemoperfusion Production Sales Market Share by Application (2020-2025)
Figure 54. China Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 58. India Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 60. ChinaTaiwan Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Hemoperfusion Production Sales Market Share by Country in 2025
Figure 62. Europe Hemoperfusion Production Revenue Market Share by Country (2020-2025)
Figure 63. Europe Hemoperfusion Production Sales Market Share byType (2020-2025)
Figure 64. Europe Hemoperfusion Production Sales Market Share by Application (2020-2025)
Figure 65. Germany Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 66.France Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Hemoperfusion Production Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Hemoperfusion Production Sales Market Share byType (2020-2025)
Figure 72. Middle East & Africa Hemoperfusion Production Sales Market Share by Application (2020-2025)
Figure 73. Egypt Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 76.Turkey Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Hemoperfusion Production Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Hemoperfusion Production in 2025
Figure 79. Manufacturing Process Analysis of Hemoperfusion Production
Figure 80. Industry Chain Structure of Hemoperfusion Production
Figure 81. Channels of Distribution
Figure 82. Global Hemoperfusion Production Sales MarketForecast by Region (2026-2031)
Figure 83. Global Hemoperfusion Production Revenue Market ShareForecast by Region (2026-2031)
Figure 84. Global Hemoperfusion Production Sales Market ShareForecast byType (2026-2031)
Figure 85. Global Hemoperfusion Production Revenue Market ShareForecast byType (2026-2031)
Figure 86. Global Hemoperfusion Production Sales Market ShareForecast by Application (2026-2031)
Figure 87. Global Hemoperfusion Production Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Hemoperfusion production Market 2018, Forecast to 2023
US$ 4,880.00
July 2018
114 pages
Global Hemoperfusion Production Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
January 2026
88 pages
Global Hemoperfusion production Market Report 2021
US$ 2,350.00
March 2021
121 pages
